Search hospitals > California > San Diego
Kaiser Permanente-San Diego Mission
Claim this profileSan Diego, California 92108
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
178 reported clinical trials
11 medical researchers
Summary
Kaiser Permanente-San Diego Mission is a medical facility located in San Diego, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Kaiser Permanente-San Diego Mission is involved with conducting 178 clinical trials across 377 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Gary L. Buchschacher, Helen H. Moon, and Eric C. McGary.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Robert M. CooperKaiser Permanente Downey Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Cancer
46 reported clinical trials
91 drugs studied
Gary L. BuchschacherKaiser Permanente-Anaheim6 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
12 reported clinical trials
33 drugs studied
Helen H. MoonKaiser Permanente-Riverside7 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
13 reported clinical trials
23 drugs studied
Eric C. McGaryKaiser Permanente-Anaheim9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Clinical Trials running at Kaiser Permanente-San Diego Mission
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Cancer
Ovarian Tumors
Small Intestinal Adenocarcinoma
Colorectal Cancer
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Multiple Therapies
for Stage III Non-Small Cell Lung Cancer
This trial is testing different treatments to see how well they work and how safe they are. It focuses on patients with advanced lung cancer that cannot be removed by surgery and have specific biological markers. The goal is to find out if these treatments can stop the cancer from growing or spreading and improve patients' health.
Recruiting2 awards Phase 317 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-San Diego Mission?
Kaiser Permanente-San Diego Mission is a medical facility located in San Diego, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Kaiser Permanente-San Diego Mission is involved with conducting 178 clinical trials across 377 conditions. There are 11 research doctors associated with this hospital, such as Robert M. Cooper, Gary L. Buchschacher, Helen H. Moon, and Eric C. McGary.